Biopharma companies Gennao Bio and Juno Diagnostics raised a combined $65 million in Series A funding rounds.
If you are not happy with the results below please do another search
50 search results for:
New mutations, or variants, of the SARS-CoV-2 virus that causes Covid-19 are continuing to be discovered. Health officials in Florida cited a new mutation of the Brazilian strain (P.1) that they are calling P2 or P.1.1.
Samsung BioLogics Co. Ltd. and Pfizer Inc. on May 12 denied a report that they were working together to produce in South Korea a Covid-19 vaccine developed by the U.S. drugmaker.
Biogen and Capsigen forged a strategic collaboration to engineer novel adeno-associated virus (AAV) capsids that have the potential to become transformative gene therapies that treat underlying genetic causes of various central nervous system and neuromuscular disorders.
2021 is shaping up to be another banner year for biotech companies. According to BioSpace, funds appear to be in near-endless supply as companies advance next-gen technologies and therapeutics for the health of all. BioSpace reviews a few raking in cash for their programs.
BioSpace takes a look at a few of the highlights of the 24th annual meeting of the ASGCT, with researchers presenting cutting-edge work in the booming area of gene and cell therapy.
AbbVie Inc.’s Allergan Aesthetics announced the acquisition of Soliton Inc. in a definitive agreement that is valued at $550 million. Allergan Aesthetics will pay $22.60 per share for each outstanding Soliton share.
India’s coronavirus crisis showed scant sign of easing on May 11, with a seven-day average of new cases at a record high and international health authorities warning the country’s variant of the virus poses a global concern.
Bold Therapeutics, a clinical-stage biopharmaceutical company, announced that the U.S. Food and Drug Administration granted BOLD-100 an Orphan Drug Designation (ODD) in the treatment of gastric (stomach) cancer.
One million Americans signed up for health insurance on the U.S. government website Healthcare.gov during a special enrollment period that began on Feb. 15, President Joe Biden said in a statement on May 11.